Single barcode scan cast system for pharmaceutical products
US-2024086486-A1 · Mar 14, 2024 · US
US10265139B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10265139-B2 |
| Application number | US-201615006291-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 26, 2016 |
| Priority date | Sep 2, 2003 |
| Publication date | Apr 23, 2019 |
| Grant date | Apr 23, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Disclosed is a medicine ingestion state management method capable of objectively managing medicine ingestion states of patients. The medicine ingestion state management method involves an operation of prescribing medicine (10) encapsulating, together with a medicament, a medicine information transmitting unit (20) having a function of transmitting medicine information capable of specifying a type and a quantity of the medicament to each individual patient, and an operation of grasping the medicine ingestion state of each patient by collecting the medicine information from each medicine information transmitting unit (20) in each patient.
Opening claim text (preview).
What is claimed is: 1. A swallowable medicament, comprising: a combination of a medicine and an IC chip, the combination being made using a material soluble by gastric juice, wherein the IC chip includes an electrode and starts a given operation using power generated by exposure of the electrode to the gastric juice, wherein the exposure of the electrode to the gastric juice is caused by dissolution of the material by the gastric juice. 2. The swallowable medicament according to claim 1 , wherein the IC chip includes a memory, and the given operation includes an access to the memory. 3. A medicament, comprising: a medicine; and an IC chip exists in the medicament in a status mixed with the medicine, wherein the IC chip has an electrode that forms a battery by contact with gastric juice and the IC chip operates in response to power supply from the battery, wherein the contact between the electrode and the gastric juice is caused by dissolution of a material soluble by the gastric juice covering the electrode. 4. A medicament, comprising: an IC chip that has an electrode to form a battery within a body and starts a given operation using power generated by exposure of the electrode to gastric juice; and a medicine that exists on a contact position with the electrode of the IC chip and is dissolved within the body, wherein the exposure of the electrode to the gastric juice is caused by dissolution of the material by the gastric juice.
for patient-specific data, e.g. for electronic patient records · CPC title
Detecting or monitoring allergy or intolerance reactions to an allergenic agent or substance · CPC title
Intestinal transmitters · CPC title
Office automation; Time management · CPC title
combined with drug delivery · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.